Series A Completed
Vedana Therapeutics Series A
US$46m raised
Announced 16 Jun 2026
Investors
Led by
- Canaan · Co-lead
- Westlake BioPartners · Co-lead
With
- DAWN Biopharma
- Alexandria Venture Investments
Investors as the sources name them; a linked name has a FundComb profile.
- Company
- Vedana Therapeutics
- Stage
- Series A
- Amount raised
- US$46m
- Company based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar rounds
- Kanvas Biosciences Series A May 2026 · US$48m · led by DCVC
- Nectar Social Series A May 2026 · US$30m · led by Menlo Ventures
- HIFI Series A Sep 2026 · US$37m · led by Left Lane Capital
- Arintra Series A Aug 2026 · US$25m · led by Peak XV Partners
- Amperos Health Series A Apr 2026 · US$16m · led by Bessemer Venture Partners
Sources
- 16 Jun 2026 Advancing Toward Migraine Freedom: Why We Invested in Vedana canaan.com